A counselee-oriented perspective on risk communication in genetic counseling: Explaining the inaccuracy of the counselees' risk perception shortly after BRCA1/2 test result disclosure

Genetics in Medicine

Volumn 13, Issue 9, 2011, Pages 800-811

  Vos, Joël ^a,f   Stiggelbout, Anne M ^a   Oosterwijk, Jan ^b   Gomez Garcia, Encarna ^c   Menko, Fred ^d   Collee, J Margriet ^e   Van Asperen, Christi J ^a   Tibben, Aad ^a,e  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f NONE   (Netherlands)

Author keywords

BRCA1 2; genetic counseling; oncology; perception; psychology

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ACCURACY; ADULT; ARTICLE; BREAST CANCER; CANCER RISK; COGNITION; FEMALE; GENETIC COUNSELING; GENETIC RISK; HEREDITY; HUMAN; INFORMATION; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; OVARY CANCER; PATIENT EDUCATION; PREDICTOR VARIABLE; PROSPECTIVE STUDY; QUESTIONNAIRE; SELF CONCEPT;

EID: 80052563885     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1097/GIM.0b013e31821a36f9     Document Type: Article

References (116)

1. Resta R, Biesecker BB, Bennett RL, et al. A new definition of genetic counseling: National Society of Genetic Counselors' Task Force Report. J Genet Couns 2006;15:77-83. (Pubitemid 43876101)
2. Smerecnik CM, Mesters I, Verweij E, De Vries NK, de Vries H. A systematic review of the impact of genetic counseling on risk perception accuracy. J Genetic Couns 2009;18:217-228.
3. Meiser B, Halliday JL. What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Soc Sci Med 2002;54:1463-1470. (Pubitemid 34309011)
4. Butow PN, Lobb EA, Meiser B, Barratt A, Tucker KM. Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review. Med J Aust 2003;178:77-81. (Pubitemid 36187626)
5. Katapodi MC, Lee KA, Facione NC, Dodd MJ. Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review. Prev Med 2004;38:388-402. (Pubitemid 38327011)
6. Vos J, Gomez-Garcia EB, Oosterwijk JC, et al. Opening the psychological black box in genetic counseling. The psychological impact of DNA-testing is predicted by the counsellees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result. Psychooncology [published online ahead of print November 10, 2010]. DOI: 10.1002/pon.1864.
7. Vos J, Jansen AM, Menko FH, van Asperen CJ, Stiggelbout AM, Tibben A. Family communication matters: the impact of telling relatives about non-pathogenic DNA-test results depends on the proband's non-verbal communication and the relatives' subjective perception. Genet Med 2011; 13:333-341.
8. Vos J, Oosterwijk JC, Gomez-Garcia E, et al. Explaining the short-term impact of DNA-testing: the counselees' perception matters, the actual BRCA1/2-result does not. Patient Educ Couns [published online ahead of print June 17, 2011]. DOI: j.pec.2011.04.017.
9. Sivell S, Elwyn G, Gaff CL, et al. How risk is perceived, constructed and interpreted by clients in clinical genetics, and the effects on decision making: systematic review. J Genet Couns 2008;17:30-63. (Pubitemid 351230515)
10. Vos J, Otten W, van Asperen C, Jansen A, Menko F, Tibben A. The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life. Psychooncology 2008;17:822-830.
11. Timmermans DR. What clinicians can offer: assessing and communicating probabilities for individual patient decision making. Horm Res 1999;51: 58-66. (Pubitemid 29301285)
12. Ockhuysen-Vermey CF, Henneman L, van Asperen CJ, Oosterwijk JC, Menko FH, Timmermans DR. Design of the BRISC study: a multicentre controlled clinical trial to optimize the communication of breast cancer risks in genetic counselling. BMC Cancer 2008;8:283.
13. Waldron CA, Van der Weijden T, Ludt S, Gallacher J, Elwyn G. What are effective strategies to communicate cardiovascular risk information to patients? A systematic review. Patient Educ Couns 2011;82:169-181.
14. Henneman L, Marteau T, Timmermans DR. Clinical geneticists' and genetic counselors' views on the communication of genetic risks: a qualitative study. Patient Educ Couns 2008;73:42-49.
15. Timmermans DR, Ockhuysen-Vermey CF, Henneman L. Presenting health risk information in different formats: the effects on participants' cognitive and emotional evaluations and decisions. Patient Educ Couns 2008;73: 443-447.
16. Klein WM, Stefanek ME. Cancer risk elicitation and communication: lessons from the psychology of risk perception. Cancer J Clin 2007;57: 147-167. (Pubitemid 46798624)
17. Heshka JT, Palleschi C, Howley H, Wilson B, Wells PS. A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genet Med 2008;10:19-32.
18. Dorval M, Gauthier G, Maunsell E, et al. No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result. Cancer Epidemiol Biomarkers Prev 2005;14:2862-2867. (Pubitemid 43068816)
19. van Dijk S, Otten W, Timmermans DR, et al. What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer. Genet Med 2005;7:239-245. (Pubitemid 40638069)
20. Vos J, Oosterwijk JC, Gomez-Garcia EB, et al. Perceiving cancer-risks and heredity-likelihood in genetic-counseling: the analysis of the counselees' recollections and interpretations of BRCA1/2-test results. Clin Genet 2011; 79:207-218.
21. van Dijk S, Otten W, van Asperen CJ, et al. Feeling at risk: how women interpret their familial breast cancer risk. Am J Med Genet A 2004;131A: 42-49. (Pubitemid 39434793)
22. Schapira MM, Davids SL, McAuliffe TL, Nattinger AB. Agreement between scales in the measurement of breast cancer risk perceptions. Risk Anal 2004;24:665-673. (Pubitemid 38857632)
23. Eibner F, Barth J, Helmes A, Bengel J. Variations in subjective breast cancer risk estimations when using different measurments for assessing breast cancer risk perception. Health Risk Soc 2006;2006:2-197.
24. Woloshin S, Schwartz LM, Black WC, Welch HG. Women's perceptions of breast cancer risk: how you ask matters. Med Decis Making 1999;19: 221-229. (Pubitemid 29321264)
25. Gurmankin Levy A, Shea J, Williams SV, Quistberg A, Armstrong K. Measuring perceptions of breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006;15:1893-1898. (Pubitemid 44664265)
26. Taylor KL, Shelby RA, Schwartz MD, et al. The impact of item order on ratings of cancer risk perception. Cancer Epidemiol Biomarkers Prev 2002;11:654-659. (Pubitemid 34760824)
27. Hanoch Y, Miron-Shatz T, Himmelstein M. Genetic testing and risk interpretation: how do women understand lifetime risk results? Judgment Decis Making 2010;5:116-123.
28. Wright AJ, Whitwell SC, Takeichi C, Hankins M, Marteau M. The impact of innumeracy on reactions to different graphic risk presentation formats: an experimental analogue study. Br J Health Psychol 2009;14:107-125.
29. Hopwood P. Breast cancer risk perception: what do we know and understand? Breast Cancer Res 2000;2:387-391. (Pubitemid 32223633)
30. Revenson TA. A contextual approach to treatment decision making among breast cancer survivors. Health Psychol 2005;24:93-98.
31. Kenen R, Ardern-Jones A, Eeles R. Family stories and the use of heuristics: women from suspected hereditary breast and ovarian cancer (HBOC) families. Sociol Health Illn 2003;25:838-865. (Pubitemid 37533091)
32. Hallowell N, Foster C, Eeles R, Ardern-Jones A, Watson M. Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer. Soc Sci Med 2004;59:553-565. (Pubitemid 38622299)
33. Etchegary H. Psychological aspects of predictive genetic-test decisions: what do we know so far? Analyses Social Issues Public Policy 2004;4:13-31.
34. Shiloh S, Gerad L, Goldman B. Patient's information needs and decision-making processes: what can be learned from genetic counselees? Health Psychol 2006;25:211-219.
35. McAllister M. Personal theories of inheritance, coping strategies, risk perception and engagement in hereditary non-polyposis colon cancer families offered genetic testing. Clin Genet 2003;64:179-189. (Pubitemid 37069449)
36. Etchegary H, Perrier C. Information processing in the context of genetic risk: implications for genetic-risk communication. J Genet Couns 2007;16: 419-432. (Pubitemid 47305502)
37. Peters E, McCaul KD, Stefanek M, Nelson W. A heuristics approach to understanding cancer risk perception: contributions from judgment and decision-making research. Ann Behav Med 2006;31:45-52.
38. Decruyenaere M, Evers-Kiebooms G, Welkenhuysen M, Denayer L, Claes E. Cognitive representations of breast cancer. Emotional distress and preventive health behaviour: a theoretical perspective. Psychooncology 2000; 9:528-536. (Pubitemid 32010926)
39. Shiloh S, Drori E, Orr-Urtregger A. Being 'at-risk' for developing cancer: cognitive representations and psychological outcomes. J Behav Med 2009; 32:197-208.
40. Rees G, Fry A, Cull A, Sutton S. Illness perceptions and distress in women at increased risk of breast cancer. Psychol Health 2004;19:749-765. (Pubitemid 40004499)
41. Julian-Reynier C, Welkenhuysen M, Hagoel L, Decruyenaere M, Hopwood P, CRISCOM Working Group. Risk communication strategies: state of the art and effectivenes in the context of cancer genetics services. Eur J Hum Genet 2003;11:725-736. (Pubitemid 37337054)
42. Kavanagh AM, Broom DH. Embodied risk: my body, myself? Soc Sci Med 1998;46:437-444.
43. Lee SJ. Uncertain futures: individual risk and social context in decision-making in cancer screening. Health Risk Soc 2010;12:101-117.
44. Vos J, Jansen AM, Menko FH, van Asperen CJ, Stiggelbout AM, Tibben A. A whisper-game perspective on the family communication of DNA-test results. Fam Cancer 2011;10:87-96.
45. Anderson G. Storytelling: a holistic foundation for genetic nursing. Holist Nurs Pract 1998;12:64-76.
46. Klitzman R. "Am I my genes?": questions of identity among individuals confronting genetic disease. Genet Med 2009;11:880-889.
47. Robertson A. Embodying risk, embodying political rationality: women's accounts of risks for breast cancer. Health Risk Soc 2010;2:219-235.
48. Gerend MA, Aiken LS, West SG. Personality factors in older women's perceived susceptibility to diseases of aging. J Pers 2004;72:243-270. (Pubitemid 38422898)
49. Radcliffe NM, Klein WM. Dispositional, unrealistic, and comparative optimism: differential relations with the knowledge and processing of risk information and beliefs about personal risk. Pers Soc Psychol Bull 2002; 28:836-846. (Pubitemid 41269844)
50. Langford IH. An existential approach to risk perception. Risk Anal 2002; 22:101-120. (Pubitemid 34258738)
51. Hallowell N. Doing the right thing: genetic risk and responsibility. Sociol Health Illn 1999;21:597-621.
52. Agincourt-Canning L. Experiences of genetic risk: disclosure and the gendering of responsibility. Bioethics 2001;15:231-247. (Pubitemid 32479190)
53. Hallowell N, Foster C, Eeles R, Ardern-Jones A, Murday V, Watson M. Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information. J Med Ethics 2003;29:74-79. (Pubitemid 36511314)
54. MacKenzie A, Patrick-Miller L, Bradbury AR. Controversies in communication of genetic risk for hereditary breast cancer. Breast J 2009;15:S25-S32.
55. Tibben A, VegtervanderVlis M, Skraastad, MI, et al. DNA-testing for Huntington's disease in the Netherlands-a retrospective study on psycho-social effects. Am J Med Genet 1992;44:94-99.
56. Esplen MJ, Stuckless N, Hunter J, et al. The development of a self-concept scale for BRCA1 and BRCA2 carriers. Psychooncology 2000;9:S4.
57. Esplen MJ, Stuckless N, Hunter J, et al. The BRCA Self-Concept Scale: a new instrument to measure self-concept in BRCA1/2 mutation carriers. Psychooncology 2009;18:1216-1229.
58. Park CL, Folkman S. Meaning in the context of stress and coping. Rev General Psychol 1997;1:115-144. (Pubitemid 127547055)
59. Skirton H. The client's perspective of genetic counseling-a grounded theory study. J Genet Couns 2001;10:311-329. (Pubitemid 33818212)
60. Low CA, Bower JE, Kwan L, Seldon J. Benefit finding in response to BRCA1/2 testing. Ann Behav Med 2008;35:61-69.
61. van Asperen CJ, van Dijk S, Zoeteweij MW, et al. What do women really want to know? Motives for attending familial breast cancer clinics. J Med Genet 2002;39:410-414. (Pubitemid 34664975)
62. Brandt R, Hartmann E, Ali Z, Tucci R, Gilman P. Motivations and concerns of women considering genetic testing for breast cancer: a comparison between affected and at-risk probands. Genet Test 2002;6:203-205. (Pubitemid 35332750)
63. Klitzman RL. Misunderstandings concerning genetics among patients confronting genetic disease. J Genet Couns 2010;19:430-446.
64. Thorne S, Hislop TG, Kuo M, Armstrong EA. Hope and probability: patient perspectives of the meaning of numerical information in cancer communication. Qual Health Res 2006;16:318-336. (Pubitemid 43263730)
65. Davey A, Rostant K, Harrop K, oldblatt J, O'Leary P. Evaluating genetic counseling: client expectations, psychological adjustment and satisfaction with service. J Genet Couns 2005;V14:197-206. (Pubitemid 40909688)
66. Foster C, Eeles R, Ardern-Jones A, Moynihan C, Watson M. Juggling roles and expectations: dilemmas faced by women talking to relatives about cancer and genetic testing. Psychol Health 2004;19:439-455. (Pubitemid 38920111)
67. Henneman L, Timmermans DR, van der Wal G. Public experiences, knowledge and expectations about medical genetics and the use of genetic information. Community Genet 2004;7:33-43. (Pubitemid 39370486)
68. Press NA, Yasui Y, Reynolds S, Durfy SJ, Burke W. Women's interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations. Am J Med Genet 2001;99:99-110. (Pubitemid 32204778)
69. Baty BJ, Dudley WN, Musters A, Kinney AY. Uncertainty in BRCAI cancer susceptibility testing. Am J Med Genet Part C Semin Med Genet 2006;142C:241-250. (Pubitemid 44747451)
70. Sammarco A. Perceived social support, uncertainty, and quality of life of younger breast cancer survivors. Cancer Nurs 2001;24:212-219. (Pubitemid 32497005)
71. Giarelli E. Spiraling out of control: one case of pathologic anxiety as a response to a genetic risk of cancer. Cancer Nurs 1999;22:327-339. (Pubitemid 29466341)
72. Smith JA, Michie S, Allanson A, Elwy R. Certainty and uncertainty in genetic counselling: a qualitative case study. Psychol Health 2000;15:1-12.
73. Bennett P, Wilkinson C, Turner J, et al. Psychological factors associated with emotional responses to receiving genetic risk information. J Genet Couns 2008;17:234-241.
74. Braithwaite D, Sutton S, Steggles N. Intention to participate in predictive genetic testing for hereditary cancer: the role of attitude toward uncertainty. Psychol Health 2002;17:761-772.
75. Cella D, Hughes C, Peterman A, et al. A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol 2002; 21:564-572. (Pubitemid 35244769)
76. Ryff CD. Happiness is everything, or is it-explorations on the meaning of psychological well-being. J Pers Soc Psychol 1989;57:1069-1081.
77. van Dierendonck D. The construct validity of Ryff's Scales of Psychological Well-being and its extension with spiritual well-being. Pers Individ Dif 2004;36:629-643.
78. Schmutte PS, Ryff CD. Personality and well-being: reexamining methods and meanings. J Pers Soc Psychol 1997;73:549-559. (Pubitemid 127453808)
79. Scheier MF, Carver CS. Effects of optimism on psychological and physical well-being-theoretical overview and empirical update. Cogn Ther Res 1992;16:201-228.
80. Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and Trait Anxiety, Self-Mastery, and Self-Esteem)-a reeval-uation of the life orientation test. J Pers Soc Psychol 1994;67:1063-1078.
81. Neuberg SL, Newsom JT. Personal need for structure: individual differences in the desire for simple structure. J Pers Soc Psychol 1993;65:113-131.
82. Weinman J, Petrie KJ, MossMorris R, Horne R. The illness perception questionnaire: a new method for assessing the cognitive representation of illness. Psychol Health 1996;11:431-445.
83. Kleijn WC, Van Heck GL, Van Waning A. Ervaringen met een Neder-landse bewerking van de COPE copingvragenlijst: de COPE-easy. Gedrag Gezondheid 2000;28:213-226.
84. Horowitz M, Wilner N, Alvarez W. Impact of event scale-measure of subjective stress. Psychosom Med 1979;41:209-218. (Pubitemid 9219271)
85. Baron RM, Kenny DA. The moderator mediator variable distinction in social psychological-research-conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173-1182.
86. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008;40:879-889.
87. Edwards A, Gray J, Clarke A, et al. Interventions to improve risk communication in clinical genetics: systematic review. Patient Educ Couns 2008; 71:4-25.
88. Breitbart WS, Alici Y. Psycho-oncology. Harv Rev Psychiatry 2009;17: 361-376.
89. Brady MJ, Peterman AH, Fitchett G, Mo M, Cella D. A case for including spirituality in quality of life measurement in oncology. Psychooncology 1999;8:417-428.
90. Thompson SC, Sobolewshubin A, Galbraith ME, Schwankovsky L, Cruzen D. Maintaining perceptions of control-finding perceived control in low-control circumstances. J Pers Soc Psychol 1993;64:293-304.
91. Taylor SE. Factors associated with meaning in life among people with recurrent cancer. Oncol Nurs Forum 1993;20:1399-1407.
92. Taylor SE. Adjustment to threatening events-a theory of cognitive adaptation. Am Psychol 1983;38:1161-1173.
93. McClain CS, Rosenfeld B, Breitbart W. Effect of spiritual well-being on end-of-life despair in terminally-ill cancer patients. Lancet 2003;361:1603-1607. (Pubitemid 36578997)
94. Nelson CJ, Rosenfeld B, Breitbart W, Galietta M. Spirituality, religion, and depression in the terminally ill. Psychosomatics 2002;43:213-220. (Pubitemid 34522531)
95. Lethborg C, Aranda S, Cox S, Kissane D. To what extent does meaning mediate adaptation to cancer? The relationship between physical suffering, meaning in life, and connection to others in adjustment to cancer. Palliat Support Care 2007;5:377-388.
96. Coward DD, Kahn DL. Transcending breast cancer: making meaning from diagnosis and treatment. J Holist Nurs 2005;23:264-283.
97. Breitbart WS, Rosenfeld B, Pessin H, et al. Depression, hopelessness and desire for death in terminally ill cancer patients. Psychosomatics 2001;42:194.
98. Schroevers M, Kraaij V, Garnefski N. How do cancer patients manage unattainable personal goals and regulate their emotions? Br J Health Psychol 2008;13:551-562.
99. Chochinov HM. Dignity-conserving care-a new model for palliative care. JAMA 2002;287:2253-2260.
100. Chochinov HM, Hack TF, McClement S, Kristjanson LJ, Harlos M. Dignity in the terminally ill: a developing empirical model. Soc Sci Med 2002;54:433-443. (Pubitemid 34028124)
101. Hopwood P. Psychosocial aspects of risk communication and mutation testing in familial breast-ovarian cancer. Curr Opin Oncol 2005;17:340-344. (Pubitemid 40904418)
102. Kasper J, Geiger F, Freiberger S, Schmidt A. Decision-related uncertainties perceived by people with cancer-modelling the subject of shared decision making. Psychooncology 2008;17:42-48. (Pubitemid 351166276)
103. van Oostrom I, Meijers-Heijboer EJ, Duivenvoorden H, et al. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study. Clin Genet 2007;71:35-42. (Pubitemid 44929338)
104. MacKinnon DP, Krull JL, Lockwood CM. Equivalence of the mediation, confounding and suppression effect. Prev Sci 2000;1:173-181.
105. O'Neill SC, Peters JA, Vogel VG, Feingold E, Rubinstein WS. Referral to cancer genetic counseling: are there stages of readiness? Am J Med Genet Part C Semin Med Genet 2006;142C:221-231. (Pubitemid 44747449)
106. Stam P, Van der Looiu E, Voorendt M, Van der Burgt I, Hoogerbrugge N. Overestimated lifetime cancer risk can be reduced by feedback on preexisting estimation. Eur J Hum Genet 2010;18.
107. Landsbergen K, Verhaak C, Kraaimaat F, Hoogerbrugge N. Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients. Fam Cancer 2005;4:115-119. (Pubitemid 40897811)
108. Breitbart W, Rosenfeld B, Gibson C, et al. Meaning-centered group psychotherapy for patients with advanced cancer: a pilot randomized controlled trial. Psychooncology 2010;19:21-28.
109. Henoch I, Danielson E. Existential concerns among patients with cancer and interventions to meet them: an integrative literature review. Psychoon-cology 2009;18:225-236.
110. LeMay K, Wilson KG. Treatment of existential distress in life threatening illness: a review of manualized interventions. Clin Psychol Rev 2008;28:472-493. (Pubitemid 351296366)
111. Lepore SJ, Coyne JC. Psychological interventions for distress in cancer patients: a review of reviews. Ann Behav Med 2006;32:85-92. (Pubitemid 44547588)
112. Williams S, Dale J. The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review. Br J Cancer 2006;94:372-390. (Pubitemid 43237562)
113. Trijsburg RW, van Knippenberg FC, Rijpma S. Effects of psychological treatment on cancer patients: a critical review. Psychosom Med 1992;54:489-517.
114. Chochinov HM, Hack TF, Hassard T, Kristjanson LJ, McClement S, Harlos M. Dignity therapy: a novel psychotherapeutic intervention for patients near the end of life. J Clin Oncol 2005;23:5520-5525.
115. Kang K-A, Im J-I, Kim H-S, Kim S-J, Song M-K, Sim S. The effect of logotherapy on the suffering, finding meaning, and spiritual well-being of adolescents with terminal cancer. J Korean Acad Child Health Nurs 2009; 15:136-144.
116. McCarthy Veach P, Bartels DM, LeRoy BS. Coming full circle: a reciprocal-engagement model of genetic counseling practice. J Genet Couns 2007;16:713-728. (Pubitemid 350077239)